Class 2 Medicines Recall: Nutriflex Omega Plus 1250ml, 1875ml and 2500ml, PL 03551/0119, and Nutriflex Omega Special 625ml, 1250ml, 1875ml and 2500ml, PL 03551/0118 and Supplemented Product codes ASNSPOMCA, ASNSPOMSVA, ASNPLOMCA, ASNPLOMSVA (625ml, 1250ml, 1875ml 2500ml) (EL(19)A/31)

B Braun is initiating a recall of certain batches of the above products as a precautionary measure. This is because ongoing product monitoring has identified that some bags may not comply with the required specification throughout the product shelf-life.

B. Braun Medical Limited

Nutriflex Omega Plus 1250ml, 1875ml and 2500ml

Nutriflex Omega Special 625ml, 1250ml, 1875ml and 2500ml

Supplemented Product codes ASNSPOMCA, ASNSPOMSVA, ASNPLOMCA, ASNPLOMSVA (625ml, 1250ml, 1875ml 2500ml)

Please refer to the Drug Alert for information on affected batches.

(EL(19)A/31)

Brief description of the problem

B Braun is initiating a recall of certain batches of the above products as a precautionary measure. This is because ongoing product monitoring has identified that some bags may not comply with the required specification throughout the product shelf-life.

Some unlicensed products have been manufactured by adding supplements to potentially affected Nutriflex Omega Plus and Nutriflex Omega Special bags, therefore certain batches of supplemented products are also being recalled.

Advice for healthcare professionals

Please check your inventory for the listed batches of both licensed and unlicensed products and quarantine and discontinue use of any affected stock immediately. Please return affected stock to your supplier using your suppliers approved process.

Company contacts for further information

For licensed stock returns please contact Catherine Clulow on 0114 225 9155, email productcomplaints.bbmuk@bbraun.com

For further information on licensed stock please contact Niki Bench, Product Manager, Clinical Nutrition on 07808 716064, email niki.bench@bbraun.com

For unlicensed specials stock control and unlicensed specials stock returns enquires please contact Adam Rose, BBCAPS Quality Manager on 01142259130, email adam.rose@bbraun.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter.

Download the document

(EL(19)A/31)

Updates to this page

Published 30 October 2019